Sequoia Financial Advisors LLC lifted its stake in Dolby Laboratories (NYSE:DLB – Free Report) by 229.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,688 shares of the electronics maker’s stock after purchasing an additional 10,231 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Dolby Laboratories were worth $943,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Horizon Corp bought a new position in Dolby Laboratories during the third quarter valued at approximately $25,000. Hantz Financial Services Inc. raised its position in Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares in the last quarter. Rothschild Investment LLC raised its position in Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after acquiring an additional 607 shares in the last quarter. Fifth Third Bancorp raised its position in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new position in Dolby Laboratories during the third quarter valued at approximately $50,000. Institutional investors own 58.56% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on DLB shares. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, January 30th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Dolby Laboratories Stock Down 2.0%
Shares of DLB stock opened at $54.28 on Thursday. Dolby Laboratories has a 12 month low of $53.45 and a 12 month high of $77.64. The business’s 50 day moving average is $61.52 and its two-hundred day moving average is $63.94. The company has a market cap of $5.14 billion, a PE ratio of 21.46 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same quarter last year, the company posted $1.34 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, equities analysts expect that Dolby Laboratories will post 3.22 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.7%. The ex-dividend date is Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio (DPR) is 56.92%.
Insider Buying and Selling at Dolby Laboratories
In other news, SVP John D. Couling sold 7,666 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the sale, the senior vice president owned 118,353 shares in the company, valued at approximately $6,811,215.15. This trade represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total transaction of $198,420.00. Following the completion of the sale, the senior vice president owned 83,218 shares in the company, valued at approximately $5,504,038.52. The trade was a 3.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 18,021 shares of company stock worth $1,090,741 over the last 90 days. Insiders own 37.93% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
